A U.S.-backed examine set to look at the general well being results of hepatitis B vaccine dose timing on some 14,000 infants within the West African nation of Guinea-Bissau has raised ethics considerations amongst scientists and former officers — and confusion amid conflicting reviews on whether or not the analysis will proceed.
